Iovance Biotherapeutics Inc. buy Wells Fargo & Company
Start price
20.02.24
/
50%
€11.70
Target price
20.02.25
€20.35
Performance (%)
-52.82%
End price
21.02.25
€5.52
Summary
This prediction ended on 21.02.25 with a price of €5.52. Massive losses of -52.82% were the result for the BUY prediction by Wells_Fargo___Compan. Wells_Fargo___Compan has a follow-up prediction for Iovance Biotherapeutics Inc. where he still thinks Iovance Biotherapeutics Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 44.434% | 44.434% | -77.138% |
| iShares Core DAX® | 1.274% | -0.174% | 23.948% |
| iShares Nasdaq 100 | -0.551% | 5.635% | 11.588% |
| iShares Nikkei 225® | -1.032% | 9.513% | 18.120% |
| iShares S&P 500 | 0.229% | 4.847% | 5.994% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Wells Fargo & Company from $17.00 to $22.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.87
08.08.25
08.08.25
€12.01
08.08.26
08.08.26
25.35%
12:11
12:11
Stopped prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.97
30.05.23
30.05.23
€15.85
30.05.24
30.05.24
4.72%
31.05.24
31.05.24